Each unit increase in serum apolipoprotein B concentration in the Q2 interval was associated with a 37.9% increased risk of osteopenia or osteoporosis, and each unit increase in serum apolipoprotein B concentration in the Q4 interval was associated with a 49.4% increased risk of osteopenia or osteoporosis. Here, APOB is linked to Osteopenia.